pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that it has elected James J. Barry, Ph.D. to its Board of Directors.
Dr. Barry, age 55, currently serves as Executive Vice President and Chief Operating Officer of InspireMD, a global medical device company focused on the development and commercialization of cardiovascular products. At InspireMD, Dr. Barry is responsible for advancing the product pipeline, managing all global clinical trial activities and driving the operational activities.
Help employers find you! Check out all the jobs and post your resume.
